Skip to main content

Table 2 Patient characteristics.

From: Comparison of rectal volume definition techniques and their influence on rectal toxicity in patients with prostate cancer treated with 3D conformal radiotherapy: a dose-volume analysis

Patients  
Age (years)  
   Median 69
   Range 48–82
Pretreatment PSA n (%)
   ≤ 10 ng/mL 37 (39)
   > 10 ng/mL 57 (61)
Gleason score n (%)
   6 55 (59)
   7 30 (32)
   8 3 (3)
   9 6 (6)
Stage n (%)
   T1 12 (13)
   T2 63 (67)
   T3 19 (20)